Marjan Cruijsen

Statistics

Publications

Citations

129

H-Index

Active since

2014

Affiliations

Radboud University Medical Center(Current)

Radboud University Nijmegen

University Medical Center Groningen

Marjan Cruijsen is an author at Radboud University Medical Center specializing in hematopoietic stem cell transplant pharmacotherapy, immunotherapy, and hematology.

ORCID

Publications per year

2014–2021

Publications

Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses

Marjan Cruijsen, Willemijn Hobo, Walter J. F. M. van der Velden et al. · Biology of Blood and Marrow Transplantation · 2016 · 49 citations · Full text

Medicine, Hematology, Pharmacology +17

Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation

Sebastian Sommer, Marjan Cruijsen, Rainer Claus et al. · Leukemia Research · 2018 · 39 citations

Medicine, Hematology, Oncology +15

DNA Methyltransferase Inhibition Promotes Th1 Polarization in Human CD4+CD25high FOXP3+ Regulatory T Cells but Does Not Affect Their Suppressive Capacity

Sija Landman, Marjan Cruijsen, Paulo C. M. Urbano et al. · Journal of Immunology Research · 2018 · 21 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Perioperative glycaemic control in insulin-treated type 2 diabetes patients undergoing gastric bypass surgery.

Marjan Cruijsen, P Koehestani, S Huttjes et al. · PubMed · 2014 · 10 citations

Medicine, Perioperative Medicine, Surgery +17

Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation

Marjan Cruijsen, Jacobien R. Hilberink, Walter J. F. M. van der Velden et al. · Bone Marrow Transplantation · 2021 · 10 citations · Full text

Medicine, Hematology, Oncology +14

1–5 of 5